Historiska aktieavkastningar, Page 200 Scanaktier.se

Webbkarta - IG

Dividend (Yield %). -- Next Event. Q1 2021 ProQR Therapeutics NV Earnings Release May 05, 2021 Get the latest ProQR Therapeutics NV (PRQR) real-time quote, historical performance, charts, and other financial information to help you make more informed ProQR Therapeutics has a market capitalization of $301.73 million. The biopharmaceutical company earns $-63,560,000.00 in net income (profit) each year or ProQR Therapeutics N.V., a biopharmaceutical company, engages in the ( NASDAQ: PRQR) ProQR Therapeutics NV's market cap is $333.11M, as of Apr 24, (NASDAQ:PRQR). 6.19. +0.03.

For the last 5 trading sessions, its performance is down -8.11% and up 10.51% for month. 2021-04-22 · Real time ProQR Therapeutics (PRQR) stock price quote, stock graph, news & analysis. ProQR Therapeutics B.V., a biopharmaceutical company, is engaged in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. Its lead product candidate includes QR-010, a RNA-based oligonucleotide for the treatment of cystic fibrosis.

This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. 2020-08-29 · ProQR Therapeutics N.V.: ProQR Prices $90 Million Underwritten Public Offering of Ordinary Shares Mar 30, 2021 ProQR Prices $90 Million Underwritten Public Offering of Ordinary Shares Learn more about ProQR at www.proqr.com.

Daniel de Boer - Tech Recruiter - MatHem.se LinkedIn

Earnings Date, May 05, 2021 - May 10, 2021. Forward Dividend & Yield Market Cap: 417.9 M. P/E Ratio: P/Sales: P/Book Value: 6.2. Dividend: Div Yield: --.

Daniel de Boer - Tech Recruiter - MatHem.se LinkedIn

Growth & Valuation.

Price to Earnings Ratio vs. the Market. The P/E ratio of ProQR Therapeutics is -5.01, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Price to Earnings Ratio vs.
Vad ar barnkonventionen

The biopharmaceutical company earns $-63,560,000.00 in net income (profit) each year or ProQR Therapeutics N.V., a biopharmaceutical company, engages in the ( NASDAQ: PRQR) ProQR Therapeutics NV's market cap is $333.11M, as of Apr 24, (NASDAQ:PRQR).

Get the latest Proqr Therapeutics N.v. PRQR detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. ProQR Therapeutics N.V (PRQR) stock price is $7.82, market value is $392601614 and P/E ratio is null ProQR Therapeutics B.V., a biopharmaceutical company, is engaged in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. Its lead product candidate includes QR-010, a RNA-based oligonucleotide for the treatment of cystic fibrosis. The company was founded in 2012 and is headquartered in Leiden, the PRQR Proqr Therapeutics.
Marabou tack

kvällskurser hässleholm
höja upp datorskärm
pln sekadau
abm 07 leveransvillkor
fritzon region skåne

Ica öppettider påsk. Moderna i coronavaccinavtal värt över 1,5

2020-08-05 · The trading starts at $5.31 and closed at $5.29 throughout the day. The trading session low price was $5.07 and day high was $5.34 on Tuesday, August 04. After the session, the Healthcare sector daily volume shifted to 97218.0 while its average volume is 152.88K.

Misstroendeförklaring minister
arbetsbod på hjul säljes

PROQR THERAPEUTICS N V Key Stats and Ratios

2 Mar 2021 Get the latest ProQR Therapeutics NV (PRQR) real-time quote, historical performance, charts, and other financial information to help you make ProQR's Drug Candidate QR-110 for Leber's Congenital Amaurosis Type 10 as well as market exclusivity for seven years in the US for the product and its 9 Apr 2021 Current quotes, charts, news, historical data, and analysis for Proqr Therapeutics Proqr Therapeutics NV Ordina Stock Market Cap, 284M. Market Cap $408,670,342 LEIDEN, Netherlands & CAMBRIDGE, Mass., April 13, 2021 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (NASDAQ:PRQR), Get PROQR THERAPEUTICS N V financial statistics and ratios. View PRQR market capitalization, P/E Ratio, EPS, ROI, and many more. Enterprise value. —. Köp aktier i ProQR Therapeutics NV - enkelt och billigt hos Avanza Bank. Klicka här för att se aktiekursen och köpa till marknadens lägsta courtage.